Ratings MedPeer,Inc.

Equities

6095

JP3921240002

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-07-05 am EDT			5-day change	1st Jan Change
598 ^JPY	+0.50%		-4.63%	-16.48%

Jun. 28	Fast Doctor Co., Ltd. agreed to acquire Cloud Clinic Co., Ltd. from MedPeer,Inc..	CI
2023	Tranche Update on MedPeer,Inc.'s Equity Buyback Plan announced on May 11, 2023.	CI

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company is in a robust financial situation considering its net cash and margin position.
With regards to fundamentals, the enterprise value to sales ratio is at 0.72 for the current period. Therefore, the company is undervalued.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the past twelve months, EPS forecast has been revised upwards.

Weaknesses

The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the past year, analysts have significantly revised downwards their profit estimates.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Internet Services

	1st Jan change	Capi.	ESG Refinitiv
MEDPEER,INC.	-16.48%	80.83M	-
TENCENT HOLDINGS LIMITED	+29.36%	447B	B
NETFLIX, INC.	+41.85%	298B	D+
UBER TECHNOLOGIES, INC.	+15.41%	148B	A-
AIRBNB, INC.	+12.02%	96.81B	C-
PROSUS N.V.	+21.68%	87.04B	B+
SPOTIFY TECHNOLOGY S.A.	+68.62%	63.07B	B-
DOORDASH, INC.	+12.21%	45.37B	C+
NASPERS LIMITED	+12.21%	33.59B	C+
COSTAR GROUP, INC.	-16.29%	29.88B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes